Abstract of the talk: Fair data sharing & data caring the digitilised era: aspirations, realities and legal clashes in the health and life sciences. Abstract: The huge prospects of Big Data, advanced machine learning and AI, as well as the shift to more “personalized”, “open” and “transparent” innovation models stress the importance of an effective governance, regulation and stimulation of shareable data-applications in the health & life sciences. Yet, cutting edge medical innovation requires more than freely available big data and machine-generated data. Pushing the boundaries of biomedical research also demands smart data and high quality data that are created and nourished through human intervention and considerable investments in an highly competitive environment. Intellectual Property Rights (IPRs) and related rights come into play when data producers protect their investment in such data. Moreover, EU data protection rules, such as the GDPR, may prevent the sharing of valuable data that is considered to be personal data. While the need of recalibrating IPRs and data protection rights to fully support “big and smart data” advances is being intensely debated, there seems to be much confusion about the availability of such rights and their legal effects. This presentation provides a very brief overview on selected areas that demonstrate emerging tensions at the interface of Big Data, Standardization, data protection, IPRs and Competition/Antitrust Law.